{"name":"Humanity and Health Research Centre","slug":"humanity-and-health-research-centre","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"SOF+DCV","genericName":"SOF+DCV","slug":"sof-dcv","indication":"Other","status":"marketed"},{"name":"SOF+PEG+RBV","genericName":"SOF+PEG+RBV","slug":"sof-peg-rbv","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"SOF+RBV","genericName":"SOF+RBV","slug":"sof-rbv","indication":"Chronic hepatitis C virus infection (genotype-dependent, primarily genotypes 2 and 3)","status":"marketed"},{"name":"Tenofovir alafenamide(TAF)","genericName":"Tenofovir alafenamide(TAF)","slug":"tenofovir-alafenamide-taf","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"marketed"}]}],"pipeline":[{"name":"SOF+DCV","genericName":"SOF+DCV","slug":"sof-dcv","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SOF+PEG+RBV","genericName":"SOF+PEG+RBV","slug":"sof-peg-rbv","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SOF+RBV","genericName":"SOF+RBV","slug":"sof-rbv","phase":"marketed","mechanism":"SOF+RBV is a combination of sofosbuvir (a nucleotide polymerase inhibitor) and ribavirin (a nucleoside analog) that inhibits hepatitis C virus replication.","indications":["Chronic hepatitis C virus infection (genotype-dependent, primarily genotypes 2 and 3)"],"catalyst":""},{"name":"Tenofovir alafenamide(TAF)","genericName":"Tenofovir alafenamide(TAF)","slug":"tenofovir-alafenamide-taf","phase":"marketed","mechanism":"Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor that blocks HIV reverse transcriptase, preventing viral replication.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults","HIV-1 infection in adolescents and children (weight-based dosing)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQejdCYUQ5dzRaVkQ2UG5MLUFvOW9oQVM5ckh4TEt3SkJFWHhJTk0wZ29xVi1zcEhFVXRQLWxxYjlGNDQwdlVrZVpJSzRGcFVLcW9tUG1LSEhHOGNpUnhVMzk0UVRpd0ViY2d0dURFWDNPd0VpdHktSTVPSWY2SWFOR0pqMWlfVjVPYzlzc29zdTZ4N0xXb2VpY1lR?oc=5","date":"2026-03-25","type":"pipeline","source":"britannica.com","summary":"Genetically modified organism - Medicine, Research, Biotechnology - britannica.com","headline":"Genetically modified organism - Medicine, Research, Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOMUJDNTZqOWNWd05Cc1JQTDF0akROak9HdjVBRVFOcXBwTXA5TTBfSzl5V0hsU3NvaVFZWmNqQ1lDdWlyZkcyZTlNWFItd1F0YTA0ZVk4QlY2ZnhrS24waDhKOFQ0VlVqSVRTdlNQUW9NZW5PY25WYWZsRzNSbmRENnhfLW9tVGNRWkxObTltbXlzRHFpZFhFM3QtQ1NTNWVJY1c1U1l0OEVIRE9NNk5xWElQMDdRQ0JPSXlUbWoxUzUzcGM2Sm8tUE1UWmVadk1w?oc=5","date":"2026-02-19","type":"deal","source":"Boehringer Ingelheim","summary":"Boehringer Ingelheim India and NIPER Raebareli sign MoU to strengthen pharmaceutical education and research collaboration - Boehringer Ingelheim","headline":"Boehringer Ingelheim India and NIPER Raebareli sign MoU to strengthen pharmaceutical education and research collaboratio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVDZ3S1d0b0NaeE9VTElZb3dUaXVGdGJfV0d5U19pRFpMQlJUV3RZT2VZMzUyLWh2MlZGaVEwY3Y3UXR1OVRieGR6YWlCR1FYNTZ5LUJ1ZEZSMWp1enBYOV96RGVqNWtBdlhHa3Joa2hLTGZfQ3RZVTRXdTlrdzhSRHlWbFc4cVZ0RlBfY3paQUZwSnU1dU1zV3NQdl9pcUR5TmFBdzI1dnhVT0RhT0JwYzhMY0RGWUttTHkxMXp3Wk56aURYUEl1cmppSjM2ckFJQlluY3dyWQ?oc=5","date":"2026-02-12","type":"pipeline","source":"The Association of the British Pharmaceutical Industry | ABPI","summary":"From models to medicines: a landscape review of human-relevant pre-clinical model development in the UK - The Association of the British Pharmaceutical Industry | ABPI","headline":"From models to medicines: a landscape review of human-relevant pre-clinical model development in the UK - The Associatio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOUDJBVGw1aE9RcVdzLTZnOUZEbGxESnZkWExES0hBWHJ5TXFwcHc3VncwSVlJVm42dThJTzRqMHlNV29SSGRUdUJfUTVNT3R5R1JCTnFGbmdfcG95cTZiQ3JRdzl0UlNXYTZ6ZW5oOEE1OW9jcVFxTU80QkRib3p5M1BJa0lpX2o5Ul96NzhZTjd2Z21sak11ckx5aUJvcENPWlE?oc=5","date":"2026-02-10","type":"trial","source":"KFF Health News","summary":"US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’ - KFF Health News","headline":"US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxONVpHVURhV0FuNjk5SkVFWl8yNlhnRFJHd0dfUW52VzdMTzBzblJFRWFMZjVDUHo3TjhYRmtvTUFja3dueE85MjVZZ3JQQV9aZEQ1amRHMmFkZXlUVUJ0UlpXMUdFbmN3OG5mR0ZldnhydG9fQl9ZUk5GSHRsQjBQRDdWRFdoaGlBN2dWdGlyMDc5U2RmUGdkWjhpRnd6Y3Joa2lQNUE4WGg4aUlWSUlmU2QyRmhSNVJ3OEpkWTRaV0hEd3g1NEI3VHRkeVVRdkxNeFJKRUpScW9XczJhUnlz?oc=5","date":"2025-12-17","type":"pipeline","source":"Boehringer Ingelheim","summary":"Translating human pharma innovation into animal health breakthroughs - Boehringer Ingelheim","headline":"Translating human pharma innovation into animal health breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPd0JVZFlXOHRueTFxZUNwZ2tiQ1F0STNaOEJPWjFCb2JHa3ozOF9Cd3lKc0V3YUUzWjM4aFFzQ2ZhWTVsQWtqemR6bmFEUjRpQmhzTDNkRkZwejZyOWRkT1lqVU5qQmlfNnFKSm9HUlk5RnlNcWhKeC02b1R4eFU1NkVyMzJtUU52eEl6V2RGcXNaNGl0VTNCMA?oc=5","date":"2025-12-11","type":"trial","source":"Murdoch University","summary":"Type 2 diabetes breakthrough nears human trial phase - Murdoch University","headline":"Type 2 diabetes breakthrough nears human trial phase","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9MSkhOMUlqWVIwUklSWkUxMnpGLW5ZRmRiNW53TEZ5Tk5kZHRlSDhnTkpScmxMSWpraVBPX0pfS2JwODRYQVlNWGFQYThDeWh2QVlVcTk4MGsybXUyMFl0Z25vMVVTZE4wRWo4bjA0QlVPM3Fp?oc=5","date":"2025-10-21","type":"pipeline","source":"The House of Commons Library","summary":"How is biomedical research infrastructure funded in the UK? - The House of Commons Library","headline":"How is biomedical research infrastructure funded in the UK?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOTXNqUnBINDNWeC1rejZEVVh1QVRWV2tIU0lYeUN1ZmowaV9MWm5HTWpJVk9sZGRTRk9DaVlVTkR5aTJWNnVFcmFOQ3FyTV9ZVHdydDQwcUNsc19PZjdoSmpQZWl1M0k2U0o3b1pnTno4emdtak81T2x3YXdJRnQ1WEVZVEtEUU9WRWo0Yjc5aWdaLURfUzdZNlMwN29WTlR5NWE1YlBn?oc=5","date":"2025-09-30","type":"pipeline","source":"today.ucsd.edu","summary":"UC San Diego Pharmacy School Moves Up to No. 4 in Research Funding Rankings - today.ucsd.edu","headline":"UC San Diego Pharmacy School Moves Up to No. 4 in Research Funding Rankings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE91bXBXb21Uei1jLVdOR2JCbVNSeG1FVlZEOUlXQjFHZkI3eW9qOTMycUZRZFZiaVNhUXpfalpZYkRIYUlVakVqU3pZY2xQenB0VWhYcnRKUTZOODRmMGc?oc=5","date":"2025-09-02","type":"pipeline","source":"Fierce Pharma","summary":"Eric Green - Fierce Pharma","headline":"Eric Green","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNUHVhTndjVkxfWHJCVXBQX1daMVJuUHZCaC1LRXl6LVcwSDF3SV9oVlNSQ2dCZjFLRkhFS01EWEJBa29GbVY5c3l1Q2hQMHBybmp6REMyTElfeGpBbXUxTlhtSmxQUFRPU3BLc1pEajFNcDFXeFV1SFZUNURMUGh0RUdmUVlHWnZ5YVk3Sm5XOFdhQ1JEQUs4SVo4NmhEdWJreEo4dmRVNzFoalNERTNZRNIBwAFBVV95cUxOSDRrMWlvODNwNXlvb2F0cnU5dVpVNE02RER6WFp1VEhSZ0R6WWRuNlZDT18wdXZiLXRBOWJTeXZ4Vkw1UHJGSlk1RmwtVjdVRXdwTkZ4WUt3R0g5ZDk2a0hESFc3eW5tMXlpaVU5cEpHZkZ1Q0Q1WmxJVjFWY2x3LXBpdlRWc1paOE5pdmEwdWdNOV9LYW1oOUd4YUVkTFBEYlZ2Sy1vQ0dhN3YxX0xldGNmUEZ4Y1R4VTFNS3l0OE8?oc=5","date":"2025-07-23","type":"pipeline","source":"University of Colorado Anschutz","summary":"Inside CU Pharmacy's Drug Discovery Lab: Quantum Technology and Human Health - University of Colorado Anschutz","headline":"Inside CU Pharmacy's Drug Discovery Lab: Quantum Technology and Human Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOcUhsd0swVm1RWnVBd3E2VVhqdXRjNkNmME9pXzA0SjVGRTlTeHFtRzFuc2hDZjhKZVZJdlY3Vkd2VzZSam96ZDY4eWtDY1pFVW9fTF9iMWFQVkNDZG4xMTF6NmhfMG5ucUt4N1ZHMThCZzlaakh3MVhIdUpKTGNrb2N4Z2ZuV3Q3cE9fVWtWcFNySzFobEJuQWhDNEE?oc=5","date":"2025-06-03","type":"pipeline","source":"Deloitte","summary":"Navigating the future of commercial in biopharma - Deloitte","headline":"Navigating the future of commercial in biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE94LU10eXlQcGhaTkR5N0RscmRfXzRYYWtpbmU4Wl9EakFnaDJkZExnemp1WkRPdFhzRkNMcUx4VjFiMDBKdkFCa1FRMEVRcjMzWHc0TmYtNkQ5cGtrbHpj?oc=5","date":"2024-03-22","type":"pipeline","source":"nature.com","summary":"Digital twins for health: a scoping review - npj Digital Medicine - nature.com","headline":"Digital twins for health: a scoping review - npj Digital Medicine","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}